FDA Panel Backs Boosters for Johnson & Johnson Vaccine Recipients FDA Panel Backs Boosters for Johnson & Johnson Vaccine Recipients

While the advisory panel felt the data supporting a booster was limited and unfocused, they unanimously backed a second shot for recipients of the J&J vaccine.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news